Bayer (BAYN) investor relations material

Strategic framework and execution

• Five-year plan focuses on sales growth, margin expansion, and cash generation, targeting over EUR 1 billion in savings across R&D, product supply, and commercial functions.

• Innovation pipeline aims to add EUR 3.5 billion to the top line, with major launches planned for 2027–2029 and beyond.

• Execution is on track, with EUR 150 million in R&D savings and significant product supply consolidation, including site closures and portfolio pruning.

• Margin expansion is supported by ongoing cost discipline and operational adjustments, with a 2026 margin target of 20–22%.

• Q1 results confirm guidance for 2026, with top-line growth of 1–4% expected in core business.

Innovation and product launches

• Seven biotech traits will launch in the U.S. and six in Brazil over the next five years, accelerating the pace of innovation.

• 75% of U.S. corn hybrids sold this year are from launches in the past three years, reflecting rapid adoption of new breeding technologies.

• Key upcoming products include Preceon short stature corn, Vyconic soybeans, and new crop protection solutions like icafolin and Plenexos.

• Vyconic's launch in 2027 will start with limited acreage but is expected to ramp quickly due to broad germplasm availability and strong farmer interest.

• Preceon is being scaled thoughtfully, with over 1,100 farmers participating and acreage doubling annually.

Market dynamics and regional trends

• U.S. corn and soybean acreage remains stable, with a slight shift from corn to soybeans; no major deviations from USDA expectations.

• In Brazil, seed price increases are expected in the low to mid-single digits, driven by innovation and value-based pricing.

• Q1 saw strong growth in seeds and traits in Brazil, with soybeans up 9% and corn also performing well.

• Uncertainty from global events, such as the Middle East conflict and fertilizer prices, may impact Latin America more significantly in the coming seasons.

• Farmers are expected to be cautious with equipment renewal and may rationalize fertilizer use, but demand for seed innovation remains robust.